1278 studies found for:    Kennedy's Disease
Show Display Options
Rank Status Study
21 Terminated
Has Results
DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: DHEA;   Procedure: Surgical resection
22 Withdrawn STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling
Condition: Adenocarcinoma of the Prostate
Interventions: Drug: STA9090;   Drug: STA9090 with Dutasteride
23 Recruiting The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ARN-509;   Drug: LHRH Agonist
24 Withdrawn Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
Condition: Breast Cancer Female
Interventions: Drug: oral microencapsulated diindolylmethane;   Other: laboratory biomarker analysis
25 Recruiting A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Intervention: Drug: JNJ-56021927
26 Recruiting A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Subjects With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) and Estrogen Receptor Negative (ER-) Metastatic or Locally Advanced Breast Cancer
Conditions: Advanced Breast Cancer;   Human Epidermal Growth Factor Receptor 2 (HER2);   HER2 Amplified
Interventions: Drug: enzalutamide;   Drug: trastuzumab
27 Completed Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Condition: Prostate Cancer
Intervention: Genetic: mutation analysis
28 Not yet recruiting AR and ER Imaging in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Other: FDHT-PET scan;   Other: FES-PET scan;   Other: CT-scan;   Other: Bone scintigraphy;   Other: Tumor biopsy
29 Recruiting CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer
Conditions: Metastatic Breast Adenocarcinoma;   Breast Cancer
Intervention: Drug: CR1447
30 Active, not recruiting Phase II Study of GTx024 in Women With Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Drug: GTx-024 9mg
31 Unknown  Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Conditions: Cancer;   Prostate Neoplasms
Interventions: Drug: goserelin with dutasteride;   Drug: goserelin with bicalutamide and dutasteride;   Drug: goserelin with bicalutamide and dutasteride and ketoconazole
32 Terminated
Has Results
Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: AndroGel;   Drug: placebo
33 Completed
Has Results
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Abiraterone;   Drug: Leuprolide;   Drug: Prednisone
34 Recruiting Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: PROSTVAC-F/TRICOM;   Biological: PROSTVAC-V/TRICOM;   Drug: Enzalutamide (Xtandi)
35 Recruiting Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: PROSTVAC-F/TRICOM;   Biological: PROSTVAC-V/TRICOM;   Drug: Enzalutamide (Xtandi)
36 Unknown  Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole
Condition: Prostate Cancer
Interventions: Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: protein analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry
37 Unknown  Prostate Cancer Antigen 3 (PCA-3) Gene Project
Conditions: Prostate Cancer;   Benign Prostatic Hypertrophy
Intervention: Biological: Taking of urines
38 Active, not recruiting Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Conditions: Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: Akt inhibitor MK2206;   Drug: bicalutamide;   Other: clinical observation
39 Unknown  Pharmacogenomic Study of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention:
40 Active, not recruiting The Effect of Hormonal Contraception on Female
Condition: Adverse Effect of Oral Contraceptives, Initial Encounter
Interventions: Other: Contraceptives, Oral, Combined;   Other: Controls

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years